Resources

This fact sheet highlights PATH's multifaceted approach to expanding vaccine solutions against influenza that are optimal for the developing world. It describes our efforts to advance the development of promising new influenza vaccines, gain a better understanding of influenza vaccine performance in children in low-resource countries, and help emerging-country manufacturers produce influenza vaccines for pandemic preparedness.

This fact sheet provides important information on the SA 14-14-2 JE vaccine manufactured by the Chengdu Institute of Biological Products. Topics include vaccine presentation, dosage, safety, and history of use.

Part of the Technology Updates series, this fact sheet describes the SoloShot project at PATH.

This fact sheet highlights PATH's work to advance the development of new vaccines against influenza that are affordable and accessible for the developing world.

This fact sheet highlights PATH's work to develop a vaccine against respiratory syncytial virus (RSV) for use in a maternal immunization strategy in the developing world that can protect infants in the critical early months of life.